2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride has been researched along with nafamostat in 2 studies
| Studies (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Trials (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Recent Studies (post-2010) (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Studies (nafamostat) | Trials (nafamostat) | Recent Studies (post-2010) (nafamostat) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 640 | 54 | 198 |
| Protein | Taxonomy | 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride (IC50) | nafamostat (IC50) |
|---|---|---|---|
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | 7.47 | |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | 7.47 | |
| ubiquitin-like modifier-activating enzyme 1 | Homo sapiens (human) | 14 | |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | 7.47 | |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 14 | |
| ubiquitin-conjugating enzyme E2 variant 1 isoform a | Homo sapiens (human) | 14 | |
| Prothrombin | Homo sapiens (human) | 1.9 | |
| Complement C1r subcomponent | Homo sapiens (human) | 0.8 | |
| Plasminogen | Homo sapiens (human) | 2.9 | |
| Cationic trypsin | Bos taurus (cattle) | 0.017 | |
| Serine protease hepsin | Homo sapiens (human) | 0.005 | |
| Trypsin-1 | Homo sapiens (human) | 0.017 | |
| Complement C1s subcomponent | Homo sapiens (human) | 0.029 | |
| Hepatocyte growth factor activator | Homo sapiens (human) | 0.15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, N; Kitagawa, S; Kitamura, H; Matsumiya, G; Matsumoto, M; Miyagawa, S; Nakano, S; Nakata, S; Seya, T; Shirakura, R | 1 |
| Cooper, DK; Hancock, WW; Kobayashi, T; Koren, E; Neethling, FA; Niekrasz, M; Takagi, H; Taniguchi, S; Ye, Y | 1 |
2 other study(ies) available for 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and nafamostat
| Article | Year |
|---|---|
Effect of anticomplement reagents, K-76 COOH and FUT175, on discordant xenograft survival.
Topics: Animals; Antibodies; Benzamidines; Complement Inactivator Proteins; Complement System Proteins; Cytotoxicity, Immunologic; Female; Graft Survival; Guanidines; Guinea Pigs; Heart Transplantation; Hemagglutination; Hemolysis; Hydroxamic Acids; Male; Rats; Rats, Inbred Lew; Transplantation, Heterologous; Transplantation, Heterotopic | 1992 |
In vitro and in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a nonhuman primate model.
Topics: Animals; Benzamidines; Cells, Cultured; Complement Inactivator Proteins; Cytotoxicity, Immunologic; Graft Rejection; Graft Survival; Guanidines; Hydroxamic Acids; Kidney; Kidney Transplantation; Papio; Sesquiterpenes; Swine | 1996 |